Investigation Overview
March 30, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Auspex Pharmaceuticals Inc (NASDAQ:ASPX), was announced concerning whether the takeover of Auspex Pharmaceuticals Inc by Teva Pharmaceutical Industries Ltd for $105.00 per share is unfair to NASDAQ:ASPX stockholders. The investigation by a law firm concerns whether certain...
You must register (for free) or login to view the entire investigation.